The Latest Cardiac and Vascular News
EDEN PRAIRIE, Minn.–(BUSINESS WIRE)–The fifth bullet in the Recent Highlights section should read: EPS of $0.11, Non-GAAP EPS of $0.07 (instead of EPS of $0.11, Non-GAAP EPS of $0.15). The correct figure of $0.07 is represented in the Second Quarter Fiscal 2018 Financial Results section and throughout the financial tables. […]
IRVINE, Calif., May 1, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, announced today that it entered into an accelerated share repurchase (ASR) agreement to repurchase an aggregate of $400 million of Edwards’ common stock. Under the terms of this ASR agreement, […]
LONE TREE, Colo., May 1, 2018 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2018 first quarter investor webcast on Tuesday, May […]
SALT LAKE CITY and INDIANAPOLIS, April 30, 2018 /PRNewswire/ — Biomerics and ATL Technology, in a joint venture (Biomerics ATL, LLC), announced on Tuesday, April 24, 2018, that they have entered into an agreement under which together they will acquire Catheter Research Inc. (CRI)‘s assets in the Indianapolis and Costa Rica divisions. CRI is a manufacturer of interventional catheters, tube sets, and other […]
LONDON & SHANGHAI–(BUSINESS WIRE)–LivaNova PLC (NASDAQ:LIVN) (“LivaNova”) and MicroPort Scientific Corporation (HK:00853) (“MicroPort”) today announced that the companies have entered into a binding Letter of Intent (“LOI”) for the sale of LivaNova’s Cardiac Rhythm Management (“CRM”) Business Franchise to MicroPort for $190 million in cash. The CRM Business Franchise develops, […]
WAYNE, Pa.–(BUSINESS WIRE)–Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, today announced the agenda for its 2018 Analyst & Investor Day, which will be held on Friday, May 11, 2018. A live webcast of the event presentations will begin at 9:00 a.m. ET. 2018 Analyst & Investor Day […]
MASON, Ohio–(BUSINESS WIRE)–AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in treatments for atrial fibrillation (Afib) and left atrial appendage (LAA) management, today announced first quarter 2018 financial results. “We are pleased with our first quarter performance and meaningful progress toward completing enrollment in CONVERGE,” said Mike Carrel, President and Chief Executive Officer […]
KIRKLAND, Wash.–(BUSINESS WIRE)–Cardiac Dimensions, a leader in the development of innovative, minimally invasive treatments for patients with heart failure, today announced the company has closed a $39 million Series B financing. The round includes new investor, Australia-based Hostplus, venture debt from Oxford Finance LLC, as well as support from existing […]
CAESAREA, Israel, April 26, 2018 /PRNewswire/ — V-Wave Ltd., an Israel-based company that has developed a proprietary, minimally invasive implanted interatrial shunt device for treating patients with severe symptomatic heart failure (HF), announced today that it has closed a Series C financing of $70 million led by Deerfield Management along with participation from new investors – […]
Conmed Corp. (CNMD) announced the company now forecasts full-year 2018 adjusted diluted net earnings per share in the range of $2.15 to $2.20, compared to the previous range of $2.11 to $2.17. This represents growth over 2017 of approximately 14% to 16%. The company now expects full-year 2018 constant-currency sales […]
